Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

LXEOLXEO
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in LEXEO THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 2.1M shares of LXEO (LEXEO THERAPEUTICS INC), worth $10M as of 2026-Q2. The position was increased (+10.2% shares). LXEO represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$10M

Current Shares

2.1M

Total Value Change

+$9.4M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.1M
+10.2%
$10M0.0%$4.66
31
2026-Q1
Increased
1.9M
+149.4%
$11.2M0.0%$7.07
45
2025-Q4
Increased
781,855
+449.1%
$7.8M0.0%$9.74
44
2025-Q3
Increased
142,402
+291.6%
$945,5490.0%$6.66
40
2025-Q2
Decreased
36,368
-54.0%
$146,2000.0%$4.12
0
2025-Q1
Decreased
79,108
-13.0%
$274,5050.0%$4.10
0
2024-Q4
New
90,901
-
$598,1290.0%$6.54
34

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used